JP2002503252A - ゴナドトロピン放出ホルモンの拮抗薬 - Google Patents

ゴナドトロピン放出ホルモンの拮抗薬

Info

Publication number
JP2002503252A
JP2002503252A JP50271499A JP50271499A JP2002503252A JP 2002503252 A JP2002503252 A JP 2002503252A JP 50271499 A JP50271499 A JP 50271499A JP 50271499 A JP50271499 A JP 50271499A JP 2002503252 A JP2002503252 A JP 2002503252A
Authority
JP
Japan
Prior art keywords
substituted
alkyl
aryl
compound
twenty
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP50271499A
Other languages
English (en)
Japanese (ja)
Inventor
グーレツト，マーク
ウージエインワラ，フエローズ
ウオルシユ，トーマス・エフ
ワイブラツト，マシユー・ジエイ，ジユニア
ヤング，ジヨナサン・アール
チユウ，リン
Original Assignee
メルク エンド カンパニー インコーポレーテッド
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9719839.4A external-priority patent/GB9719839D0/en
Priority claimed from GBGB9800451.8A external-priority patent/GB9800451D0/en
Application filed by メルク エンド カンパニー インコーポレーテッド filed Critical メルク エンド カンパニー インコーポレーテッド
Publication of JP2002503252A publication Critical patent/JP2002503252A/ja
Pending legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/09—Luteinising hormone-releasing hormone [LHRH], i.e. Gonadotropin-releasing hormone [GnRH]; Related peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/08—Drugs for disorders of the urinary system of the prostate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/02—Drugs for disorders of the endocrine system of the hypothalamic hormones, e.g. TRH, GnRH, CRH, GRH, somatostatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08—Bridged systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/08—Bridged systems
JP50271499A 1997-06-05 1998-06-01 ゴナドトロピン放出ホルモンの拮抗薬 Pending JP2002503252A (ja)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US4863797P 1997-06-05 1997-06-05
US4863697P 1997-06-05 1997-06-05
GB9719839.4 1997-09-18
GBGB9719839.4A GB9719839D0 (en) 1997-09-18 1997-09-18 Antogonists of gonadotropin releasing hormone
GB9800451.8 1998-01-09
GBGB9800451.8A GB9800451D0 (en) 1998-01-09 1998-01-09 Antagonists of gonadotropin releasing hormone
GB60/048,637 1998-01-09
GB60/048,636 1998-01-09
PCT/US1998/011204 WO1998055119A1 (fr) 1997-06-05 1998-06-01 Antagonistes de l'hormone de liberation de la gonadotrophine

Publications (1)

Publication Number Publication Date
JP2002503252A true JP2002503252A (ja) 2002-01-29

Family

ID=27451701

Family Applications (1)

Application Number Title Priority Date Filing Date
JP50271499A Pending JP2002503252A (ja) 1997-06-05 1998-06-01 ゴナドトロピン放出ホルモンの拮抗薬

Country Status (5)

Country Link
EP (1) EP1011667A4 (fr)
JP (1) JP2002503252A (fr)
AU (1) AU7806998A (fr)
CA (1) CA2291829A1 (fr)
WO (1) WO1998055119A1 (fr)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999021557A1 (fr) * 1997-10-28 1999-05-06 Merck & Co., Inc. Antagonistes de la gonadoliberine
AU1124399A (en) * 1997-10-28 1999-05-17 Merck & Co., Inc. Antagonists of gonadotropin releasing hormone
US6346534B1 (en) 1998-09-23 2002-02-12 Neurocrine Biosciences, Inc. Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
US6537998B1 (en) 1999-10-15 2003-03-25 Neurocrine Biosciences, Inc. Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
DK1255738T3 (da) 2000-01-25 2012-06-25 Neurocrine Biosciences Inc Gonadotropin-frigivende hormonreceptor-antagonister og fremgangsmåder relateret dertil
GB0022670D0 (en) 2000-09-15 2000-11-01 Astrazeneca Ab Molecules
SE0100566D0 (sv) 2001-02-20 2001-02-20 Astrazeneca Ab Compounds
SE0101692D0 (sv) 2001-05-14 2001-05-14 Astrazeneca Ab Compounds
WO2003013528A1 (fr) 2001-08-02 2003-02-20 Neurocrine Biosciences, Inc. Pyridin-4-ones substituees et leur utilisation en tant qu'antagonistes du recepteur de l'hormone de liberation de la gonadotrophine
AU2002324586B2 (en) 2001-08-02 2008-04-24 Neurocrine Biosciences, Inc. 1,3,5-triazine-2,4,6-triones, preparation and use as gonadotropin-releasing hormone receptor antagonists
EP1412363A1 (fr) 2001-08-02 2004-04-28 Neurocrine Biosciences, Inc. Antagonistes du recepteur de l'hormone liberatrice de la gonadotropine
WO2003011293A2 (fr) 2001-08-02 2003-02-13 Neurocrine Biosciences, Inc. Antagonistes du recepteur de l'hormone liberant la gonadotropine et procedes associes
WO2003011841A1 (fr) 2001-08-02 2003-02-13 Neurocrine Biosciences, Inc. 1,2,4-triazin-3,5-diones comme antagonistes du recepteur de l'hormone de liberation des gonadotrophines (gnrh)
TW200407127A (en) 2002-08-21 2004-05-16 Astrazeneca Ab Chemical compounds
DE60318716T2 (de) 2002-08-21 2009-01-08 Astrazeneca Ab Thieno-pyrrole verbindungen als antagonisten der gonadotropin-freisetzenden hormonrezeptoren
TW200413351A (en) 2002-08-21 2004-08-01 Astrazeneca Ab Chemical compounds
GB0219472D0 (en) 2002-08-21 2002-10-02 Astrazeneca Ab Chemical compounds
WO2004018459A1 (fr) 2002-08-21 2004-03-04 Astrazeneca Ab Derives de pyrazole en tant qu'inhibiteurs de gnrh
CA2531507C (fr) 2003-07-07 2013-10-01 Neurocrine Biosciences, Inc. Derives de pyrimidine-2,4-dione, servant d'antagonistes au recepteur de l'hormone de liberation de la gonadotropine
ATE557007T1 (de) 2003-07-07 2012-05-15 Neurocrine Biosciences Inc Arylpyrimidine geeignet zur behandlung von sexualhormonbedingten zuständen wie endometriose, prostatakrebs und dergleichen
DK1646389T3 (da) 2003-07-07 2009-01-05 Neurocrine Biosciences Inc Pyrimidin-2,4-dionderivater som gonadotropinfrigörende hormonreceptorantagonister
WO2012175514A1 (fr) 2011-06-21 2012-12-27 Bayer Intellectual Property Gmbh Dérivés de pyridinone et compositions pharmaceutiques les contenant

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU709090B2 (en) * 1995-12-14 1999-08-19 Merck & Co., Inc. Antagonists of gonadotropin releasing hormone

Also Published As

Publication number Publication date
EP1011667A4 (fr) 2001-03-28
EP1011667A1 (fr) 2000-06-28
AU7806998A (en) 1998-12-21
WO1998055119A1 (fr) 1998-12-10
CA2291829A1 (fr) 1998-12-10

Similar Documents

Publication Publication Date Title
US6197975B1 (en) Antagonists of gonadotropin releasing hormone
JP2002502427A (ja) ゴナドトロピン放出ホルモンの拮抗薬
JP3230818B2 (ja) ゴナドトロピン放出ホルモン拮抗剤
JP2002503252A (ja) ゴナドトロピン放出ホルモンの拮抗薬
JP2002502426A (ja) ゴナドトロピン放出ホルモンの拮抗薬
JP2002502422A (ja) ゴナドトロピン放出ホルモンの拮抗薬
JPH11501329A (ja) ゴナドトロピン放出ホルモン拮抗剤
JPH11504040A (ja) ゴナドトロピン放出ホルモン拮抗剤
US6156772A (en) Antagonists of gonadotropin releasing hormone
DE69911023T2 (de) Antagonisten des gonadotropin freisetzenden hormons
US5981550A (en) Antagonists of gonadotropin releasing hormone
JP2001520996A (ja) 性腺刺激ホルモン放出ホルモン拮抗薬
JP2001520997A (ja) 性腺刺激ホルモン放出ホルモン拮抗薬
US6159989A (en) Antagonists of gonadotropin releasing hormone
JP2002538205A (ja) 性腺刺激ホルモン放出ホルモン拮抗薬としての６−アザインドール化合物
US6156767A (en) Antagonists of gonadotropin releasing hormone
US6004984A (en) Antagonists of gonadotropin releasing hormone
JP2002503661A (ja) 性腺刺激ホルモン放出ホルモン拮抗薬
JP2002502428A (ja) ゴナドトロピン放出ホルモンの拮抗薬
JP2002503660A (ja) 性腺刺激ホルモン放出ホルモン拮抗薬
JP2002538206A (ja) 性腺刺激ホルモン放出ホルモン拮抗薬としての６−アザインドール化合物
US5985901A (en) Antagonists of gonadotropin releasing hormone
US6159975A (en) Antagonists of gonadotropin releasing hormone